STAT May 26, 2023
Helen Branswell

When a new and hoped-to-be safer oral polio vaccine started to make its way into use in March 2021, there was huge optimism that this long-needed tool would help the polio eradication campaign quell a growing problem that was — and is still — complicating efforts to stamp out polio forever.

Two years later, expectations surrounding the new vaccine, known as novel oral polio vaccine type 2, or nOPV2 for short, are moderating a bit. It has since become clear it is a safe and effective tool, one that is much less likely to give rise to the aforementioned problem, in which live viruses used in an earlier type of oral vaccine overcame genetic changes made to weaken them, and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
Patient with 3-year bout of insomnia diagnoses the cause himself
UN says nearly 40 million people had HIV in 2023, lack of treatment means someone died every minute
Listeria outbreak linked to deli meat causes 2 deaths
COVID-19's impact on maternal mortality demands rethink of public health strategies
AIDS Will Not Be Cured by 2030, Says New UNAIDS Report | AIDS 2024

Share This Article